Jan Schmidt-brand

Biography

Jan Schmidt-Brand has been Chief Financial Officer and member of the Executive Board of WILEX AG since September 1, 2012 and also serves as CEO of the subsidiary Heidelberg Pharma GmbH. Until the acquisition by WILEX AG Dr Schmidt-Brand held the position of CEO/CFO in the former Heidelberg Pharma AG. The doctor of law has over 20 years’ experience in leading positions in the commercial as well as the fiscal sector of pharmaceutical companies. From 1997 to 2001 he was Managing Director of EBEWE Arzneimittel GmbH, an Austrian BASF Pharma subsidiary. Prior to this, he held several positions at the BASF Group for a total of eight years, most recently as an executive in the central tax department with a general commercial power of attorney (“Prokurist”). Dr Jan Schmidt-Brand studied law, business management and French at the universities of Bayreuth and Geneva and obtained his doctoral degree from the University of Mannheim. He has been member of the board of directors of BIO Deutschland e.V. and head of the Finance and Tax working group since 2007. Furthermore, Dr Schmidt-Brand is a deputy Supervisory Board member of BIOPRO Baden-Württemberg GmbH and spokesman of the Industrial Advisory Board of the Faculty of Biotechnology at the Mannheim University of Applied Sciences.

Research Interest

Law, business management